Compared to the placebo, genistein significantly reduced the serum insulin levels (p = 0.001) and significantly improved insulin resistance (homeostasis model assessment of insulin resistance (HOMA-IR), p = 0.041) [111]. The gene discussed is INS; the disease is Insulin resistance.